Exploring methodology for investigating Chinese coronary artery disease patient values and preferences: A

Changning Liu1,2, Gordon Guyatt3,4,5, Yunxian Zhou6

  • 1Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.

Insights

This study addresses challenges in determining minimal important differences (MIDs) for patient outcomes in coronary artery disease (CAD). It outlines a methodology to survey patient values and establish MIDs for improved clinical guidelines.

Area of Science:

  • Cardiovascular Medicine
  • Health Services Research
  • Patient-Reported Outcomes

Background:

  • Coronary artery disease (CAD) is a major global health concern, leading to significant mortality and disability.
  • CAD patients experience a critical balance between the benefits of antithrombotic therapy and the risks of bleeding.
  • Incorporating patient values and preferences into clinical guidelines is essential for effective CAD management.

Purpose of the Study:

  • To develop a robust methodology for establishing minimal important differences (MIDs) in patient-important outcomes for coronary artery disease (CAD).
  • To create standard materials for surveying patient values and determining MIDs specifically within the Chinese CAD patient population.
  • To provide a foundation for future research on patient-important outcomes and inform clinical guideline development.

Main Methods:

  • A multidisciplinary working group guided the investigation through a three-phase process.
  • Key outcomes were identified via literature review and expert discussion.
  • Draft health outcome descriptions were synthesized from existing evidence and patient interviews, refined through cognitive interviews.
  • Outcome-specific draft MID questionnaires were developed and assessed for clarity using cognitive interviews.

Main Results:

  • The study outlines a systematic approach to developing patient-centered outcome measures for CAD.
  • Methodological challenges in directly surveying patients for MIDs are addressed.
  • Standardized materials for surveying patient values and determining MIDs are being developed.

Conclusions:

  • This research will yield essential tools for assessing patient values in CAD.
  • The developed methodology will facilitate the determination of MIDs for patient-important outcomes.
  • The findings will significantly contribute to evidence-based clinical guideline development for CAD patients.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
423
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
866
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
468
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
913
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K